🇺🇸 FDA

Intelligence · Clinical Pipeline

Pfizer Pipeline

All ClinicalTrials.gov programs at Pfizer — phase, modality, and trial IDs.

Programs
58

Quick answer

Pfizer has 58 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. ATM-AVI

    Pfizer

    Serious Bacterial Infection

    phase 3 other terminated

    1 trial

  2. ATM-AVI

    Pfizer

    Complicated Intra-abdominal Infection

    phase 3 small molecule completed

    1 trial

  3. Amlodipine/atorvastatin single pill

    Pfizer

    Hypertension

    phase 3 small molecule completed

    1 trial

  4. Anidulafungin

    Pfizer

    Candidemia

    phase 3 small molecule completed

    1 trial

  5. Avelumab

    Pfizer

    Advanced Malignancies

    phase 3 small molecule active

    1 trial

  6. Bevacizumab

    Pfizer

    Renal Cell Carcinoma

    phase 3 small molecule completed

    1 trial

  7. Bevacizumab-Pfizer

    Pfizer

    Non-Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  8. Bosutinib

    Pfizer

    Chronic Myeloid Leukemia

    phase 3 small molecule completed

    1 trial

  9. Brentuximab vedotin

    Pfizer

    Diffuse Large B-cell Lymphoma

    phase 3 small molecule active

    1 trial

  10. CAZ-AVI

    Pfizer

    Complicated Intra-Abdominal Infection

    phase 3 small molecule completed

    1 trial

  11. CP 751,871 (Figitumumab)

    Pfizer

    Carcinoma, Large Cell

    phase 3 small molecule terminated

    1 trial

  12. CP-690,550

    Pfizer

    Arthritis, Rheumatoid

    phase 3 small molecule completed

    3 trials

  13. Capecitabine

    Pfizer

    Breast Neoplasms

    phase 3 small molecule terminated

    1 trial

  14. Ceftaroline

    Pfizer

    Community-Acquired Bacterial Pneumonia

    phase 3 small molecule completed

    1 trial

  15. Ceftazidime - Avibactam ( CAZ-AVI)

    Pfizer

    Complicated Urinary Tract Infection

    phase 3 small molecule completed

    1 trial

  16. Ceftazidime-avibactam

    Pfizer

    Complicated Intra-abdominal Infection

    phase 3 small molecule completed

    1 trial

  17. Chemotherapy + avelumab followed by avelumab + talazoparib

    Pfizer

    Ovarian Cancer

    phase 3 small molecule terminated

    1 trial

  18. Edotecarin

    Pfizer

    Glioblastoma

    phase 3 small molecule completed

    1 trial

  19. Eplerenone

    Pfizer

    Heart Failure

    phase 3 small molecule completed

    1 trial

  20. Eplerenone

    Pfizer

    Hypertension

    phase 3 small molecule completed

    2 trials

  21. MenACWY-TT

    Pfizer

    Meningococcal ACWY Disease

    phase 3 mab completed

    1 trial

  22. Moxifloxacin

    Pfizer

    Chronic Bronchitis

    phase 3 small molecule completed

    1 trial

  23. PD-0332991

    Pfizer

    Breast Neoplasms

    phase 3 small molecule completed

    1 trial

  24. PF-02341066

    Pfizer

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule completed

    2 trials

  25. PF-05280014

    Pfizer

    Metastatic Breast Cancer

    phase 3 mab completed

    1 trial

  26. PF-05280586

    Pfizer

    Follicular Lymphoma

    phase 3 mab completed

    1 trial

  27. PF-06438179

    Pfizer

    Rheumatoid Arthritis

    phase 3 mab completed

    1 trial

  28. PF-06651600 Induction Dose

    Pfizer

    Alopecia Areata

    phase 3 small molecule completed

    1 trial

  29. PF-06801591

    Pfizer

    Non-muscle Invasive Bladder Cancer

    phase 3 small molecule active

    1 trial

  30. PF-07275315 dose 1

    Pfizer

    Moderate to Severe Chronic Obstructive Pulmonary Disease

    phase 3 small molecule active

    1 trial

  31. PF-07321332

    Pfizer

    COVID-19

    phase 3 small molecule completed

    2 trials

  32. Palbociclib

    Pfizer

    Metastatic Breast Cancer

    phase 3 small molecule completed

    1 trial

  33. Placebo

    Pfizer

    Ulcerative Colitis

    phase 3 small molecule completed

    1 trial

  34. Pregabalin Dose Level 1

    Pfizer

    Partial Onset Seizures

    phase 3 small molecule completed

    1 trial

  35. Quadrivalent influenza modRNA vaccine

    Pfizer

    Influenza, Human

    phase 3 mab completed

    1 trial

  36. RSVpreF

    Pfizer

    Respiratory Tract Infection

    phase 3 mab completed

    1 trial

  37. Rimegepant

    Pfizer

    Migraine

    phase 3 small molecule active

    1 trial

  38. Sigvotatug Vedotin

    Pfizer

    Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  39. Sitaxsentan

    Pfizer

    Pulmonary Arterial Hypertension

    phase 3 small molecule terminated

    1 trial

  40. Tamoxifen

    Pfizer

    Breast Neoplasms

    phase 3 small molecule completed

    1 trial

  41. Timolol

    Pfizer

    Glaucoma

    phase 3 small molecule completed

    1 trial

  42. Tofacitinib 5 mg BID

    Pfizer

    Psoriatic Arthritis

    phase 3 small molecule completed

    1 trial

  43. Zavegepant

    Pfizer

    Migraine

    phase 3 small molecule completed

    1 trial

  44. Ziprasidone

    Pfizer

    Bipolar Disorder

    phase 3 small molecule completed

    1 trial

  45. azithromycin SR (Zithromax; compound: CP-62,993)

    Pfizer

    Bronchitis, Chronic

    phase 3 small molecule completed

    1 trial

  46. azithromycin sustained release

    Pfizer

    Pneumonia

    phase 3 small molecule completed

    1 trial

  47. bapineuzumab

    Pfizer

    Alzheimer Disease

    phase 3 small molecule terminated

    1 trial

  48. bococizumab (PF-04950615)

    Pfizer

    Cardiovascular Disease

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

How many pipeline programs does Pfizer have?

58 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.